UNCY
Unicycive Therapeutics (UNCY)
$56
About Unicycive Therapeutics (UNCY)
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.
Details
Daily high
$5.58
Daily low
$5.37
Price at open
$5.45
52 Week High
$11.00
52 Week Low
$3.71
Market cap
119.5M
Dividend yield
0.00%
Volume
390,059
Avg. volume
368,058
P/E ratio
-1.71
Unicycive Therapeutics News
Details
Daily high
$5.58
Daily low
$5.37
Price at open
$5.45
52 Week High
$11.00
52 Week Low
$3.71
Market cap
119.5M
Dividend yield
0.00%
Volume
390,059
Avg. volume
368,058
P/E ratio
-1.71